Keywords: ANOVA; a one-way analysis of variance; CFU; colony forming units; DMEM; Dulbecco's modified Eagle medium; ELISA; enzyme-linked immunosorbent assay; FBS; fetal bovine serum; G-CSF; granulocyte colony-stimulating factor; 5-HMF; 5-hydroxymethylfurfural; LPS;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Chronic spontaneous urticaria (CSU); Endothelial cells; Extrinsic coagulation pathway eosinophils; Histamine; Tissue factor (TF); CSU; chronic spontaneous urticarial; TF; tissue factor; PAR; protease activated receptor; HUVEC; human umbilical vein endothe
Keywords: AP-1; activator protein 1; DAMP; damage associated molecular patterns; IRAK1; interleukin-1 receptor associated kinase-1; LBP; LPS binding protein; LPS; lipopolysaccharide; MAPK; mitogen-activated protein kinase; MD2; myeloid differentiation factor 2; MHC
Keywords: NETs; neutrophil extracellular traps; VTE; venous thromboembolism; PE; pulmonary embolism; DIC; disseminated intravascular coagulation; DVT; deep vein thrombosis; TF; tissue factor; MP; microparticle; CP; cancer procoagulant; MMP; matrix metalloproteinase
Keywords: CCK; cholecystokinin; CNS; central nervous system; EEC; enteroendocrine cell; FFAR; free fatty acid receptor; GABA; gamma-aminobutyric acid; GI; gastrointestinal; GLP; glucagon-like peptide; IB4; isolectin B4; IBD; inflammatory bowel disease; LPS; lipopol
Keywords: Toll-like receptor-2; TLR; SNPs; Polymorphism; Indian zebu; Cattle; Bos taurus;
Keywords: TLR; Memory; Verbal memory tests; Construct structure;
Keywords: dsRNA; double-stranded RNA; HTN-preg; hypertension during pregnancy; KO; knockout; Poly I:C; polyinosinic:polycytidylic acid; TLR; toll-like receptor; WT; wild-type; Hypertension; Pregnancy; Proteinuria; Innate immunity; Inflammation;
Keywords: DHA; docosahexaenoic acid; EPA; eicosapentaenoic acid; PPARs; peroxisome proliferator-activated receptors; TLR; Toll-like receptor; NF-KB; nuclear factor kappa-light-chain-enhancer of activated B cells; 5-HT; 5-hydroxytryptamine (serotonin); PUFAs; polyun
Keywords: Alarmin; Bronchial asthma; IL-33; Innate immunity; Platelets; ADP; adenosine diphosphate; AERD; aspirin-exacerbated respiratory disease; cysLT; cysteinyl leukotriene; DAMPs; danger-associated molecular patterns; EETosis; eosinophil extracellular DNA trap
Keywords: Hyperglycemia; Placenta; Inflammatory cytokines; Inflammasome; IL-1β; interleukin-1β; IL-6; interleukin-6; MCP-1; monocyte chemoattractant protein-1; TNF-α; tumor necrosis factor alpha; IL-10; interleukin 10; iNOS; inducible nitric oxide synthase; TLR;
Keywords: ACC; acetyl-CoA carboxylase; ADPH; adipophilin; Akt/PKB; protein kinase B; ALOX5; arachidonate 5-lipoxygenase; BTN1A1; butyrophilin subfamily 1 member a1; CIDEA; cell death-inducing DNA fragmentation factor α-like effector A; COX2; cyclooxygenase 2; DGAT
Keywords: M.tb; Mycobacterium tuberculosis; AT; alveolar epithelial cell; ALF; alveolar lining fluid; TB; tuberculosis; P-L; phagosome - lysosome; SP-A; surfactant protein - A; SP-D; surfactant protein - D; IL; interleukin; MHC; major histocompatibility complex; TL
Keywords: ATG; autophagy-related proteins; CMA; chaperone-mediated autophagy; ULK1; Unc-51-like kinase 1; PI3K; phosphatidylinositol 3-kinase; mTOR; mammalian target of rapamycin; PE; phosphatidylethanolamine; IFN-γ; interferon-γ; IL-1; interleukin-1; IL-17; inte
Keywords: Ictal; Source localization; Electric source imaging; EpiSource; Epilepsy surgery; amTLR; anteromesial temporal lobe resection; ESI; electrical source imaging; IOSL; ictal onset source localization; LAURA; local autoregressive average; LORETA; low resoluti
Keywords: C3aR; C3a receptor; C5aR1/2; C5a receptor 1/2; CLP; cecal ligation and puncture; CXCR4; C-X-C chemokine receptor type 4; DAMPs/PAMPs; damage-/pathogen-associated molecular patterns; Efb; extracellular fibrinogen-binding protein; ERK; extracellular signal-
Keywords: Restraint stress; Rat; Depression; UPR; TLR; Hippocampus;
Keywords: ADP; adenosine diphosphate; APC; activated protein C; AT-III; antithrombin III; ATP; adenosine triphosphate; cAMP; cyclic adenosine monophosphate; CLP; cecal ligation - perforation; DIC; disseminated intravascular coagulation; LPS; lipopolysaccharide; IL-
Keywords: ARG-1; arginase 1; CCL-; CC motif chemokine ligand-; CXCL-; CX-C motif chemokine ligand-; CAF; cancer associated fibroblast; CO; carbon monoxide; CVB3; coxsackievirus B3; COX-2; cyclooxygenase-2; DC; dendritic cell; EAU; experimental autoimmune uveitis; E
Keywords: BMP; bone morphogenetic protein; CCL; chemokine (C-C motif) ligand; CCR; chemokine receptor; CM; conditioned medium; CXCR; CXC chemokine receptors; DAMP; damage-associated molecular patterns; ECM; extracellular matrix; EV; extracellular vesicle; FGF; fibr
Keywords: drug-eluting balloon; in-stent restenosis; paclitaxel-coated balloon; percutaneous coronary intervention; target lesion failure; BSR; drug-eluting balloon-to-stent ratio; CI; confidence interval; DEB; drug-eluting balloon; DES; drug-eluting stent(s)
Keywords: Resistin-like molecule; Macrophage; Helminth infection; T helper type 2; Toll-like Receptor 4; ABC; ATP-binding cassette transporter; ADD1; adipocyte determination and differentiation dependent factor 1; ADSF; adipocyte secreted factor; Akt (aka PKB); pro
Keywords: Cervicovaginal explant; Mucosal immunology; Sexually transmitted infections; Tissue culture; Resident immune cells; CVEx; Cervicovaginal explant; STI; Sexually transmitted infections; MAIT; Mucosal-associated invariant T cells; TRM; Resident memory T cell
Keywords: AGE; advanced glycation end products; AICAR; 5-Aminoimidazole-4-carboxamide ribonucleotide; AMPK; 5â² adenosine monophosphate-activated protein kinase; APC; antigen-presenting cell; Atg7; autophagy-related gene 7; ATP; adenosine triphosphate; ATRA; all-t
Keywords: CP; cerebral Palsy; CSF; cerebrospinal fluid; HI; hypoxia-ischemia; HIE; hypoxic-ischemic encephalopathy; hAECs; human amnion epithelial cells; MCAO; middle cerebral artery occlusion; MSCs; mesenchymal stem cells; MRI; magnetic resonance imaging; NSCs; ne
Keywords: Cochlea; Immunity; Macrophage; Inflammation; TLR; Toll-like receptor; RIG-I; Retinoic acid inducible gene-I; MDA5; Melanoma differentiation-associated gene 5; TGF-β; Transforming growth factor beta; MHC-II; major histocompatibility complex II; ICAM-1; In
Keywords: granulomatous inflammation; pulmonary fibrosis; sarcoidosis; IFN; interferon; NLR; nucleotide-binding oligomerization domain-like receptor; SAA; serum amyloid A; Th; T helper; TLR; toll-like receptor; TNF; tumor necrosis factor; Treg; regulatory T;
Keywords: Fungi; innate immunity; adaptive immunity; airway; ABPM; Allergic bronchopulmonary mycosis; AFRS; Allergic fungal rhinosinusitis; AHR; Airway hyperreactivity; CLR; C-type lectin receptor; CRS; Chronic rhinosinusitis; DC; Dendritic cell; DC-SIGN; Dendritic
Keywords: FDA; US Food and Drug Administration; BCG; Calmette and Guerin; DC; dendritic cell; APCs; antigen-presenting cells; TSAs; tumor specific antigens; TRA; tumor rejection antigen; gp96; glycoprotein of 96â¯kDa; CTLs; cytotoxic T cells; SEREX; serological an
Keywords: Glucocorticoids; Opioid receptors; Pituitary-adrenal system; Psychological stress; Regulatory T lymphocytes; ACC; anterior cingulate cortex; β2AR; β2-adrenergic receptor; ACTH; adrenocorticotropic hormone; ADCYAP1R1; adenylate cyclase-activating polypep
Keywords: Anti-tumor immunity; Immune suppression; Immune memory; Drug development; Anti-cancer drug scheduling; DC; dendritic cell; ICD; immunogenic cell death; IFN; interferon; MEDIC; medium-dose intermittent chemotherapy; MTD; maximum tolerated dose; NK; natural
Keywords: ADAM; a disintegrin and metalloproteinase; APP; amyloid precursor protein; APC; antigen presenting cell; Aβ; β-amyloid; B7-H1; B7-homolog 1; CARD; caspase activation and recruitment domain; CCR; C-C chemokine receptor; CIM; C-protein induced myositis; C
Keywords: Flow cytometry; Intracellular protein; Monoclonal antibody; Primary immunodeficiency disease; Surface protein; ADA; adenosine deaminase; ALPS; autoimmune lymphoproliferative syndrome; APECED; autoimmune polyendocrinopathy-candidiasis-ectodermal dystrop
Keywords: Endotoxin limit; Regenerative medicine products; Human mesenchymal stem cells; Bone differentiation; LPS; Lipopolysaccharide; FGF; Fibroblast growth factor; BMP; Bone morphogenetic protein; CD; cluster of differentiation; LC-MS/MS; liquid chromatograph-ta
Keywords: bifurcation lesion; left main coronary artery; percutaneous coronary intervention; ACS; acute coronary syndrome(s); CABG; coronary artery bypass; C-DES; current-generation drug-eluting stent(s); CI; confidence interval; CKD; chronic kidney disease; DES; d
Keywords: ATP; Adenosine 5c-triphosphate; ALT; Alanine aminotransferase; aa; Amino acid; ASK1; Apoptosis signal- regulating kinase 1; AST; Aspartate aminotransferase; BASH; Both alcoholic and non-alcoholic liver disease; CCR2/CCR5; C-C chemokine receptor types 2 an
Keywords: DAMPs; danger associated molecular patterns; ER; endoplasmic reticulum; HMGB1; high mobility group box 1; IL-1Ra; IL-1 receptor antagonist; LPS; lipopolysaccharide; MS; mass spectrometry; PAMPs; pathogen associated molecular patterns; SDC; sodium deoxycho
Keywords: ADA; anti-drug antibodies; AMPK; 5â² adenosine monophosphate-activated protein kinase; aHUS; atypical hemolytic uremic syndrome; AMD; age-related macular degeneration; APC; antigen presenting cells; AT; anaphylatoxin; BTK; Bruton's tyrosine kinase; C1q
Keywords: ALA; alpha-linolenic acid; LA; linoleic acid; EPA; eicosapentaenoic acid; DHA; docosahexaenoic acid; PUFAs; polyunsaturated fatty acids; Cd; cadmium; SGR; specific growth rate; FCR; feed conversion ratio; ACH50; alternative complement pathway; RBA; respir
Keywords: new-generation drug-eluting stents; patient-level pooled analysis of women; percutaneous coronary intervention; stent length per lesion; stent length per patient; CI; confidence interval; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); HR; ha
Keywords: ad-virDRP1K38A; dominant-negative DRP1; AICAR; 5-aminoimidazole-4-carboxamide ribonucleotide; ATP5; ATP synthase subunit 5; DAG; diacylglycerol; DRP1; dynamin related protein 1; ER; endoplasmic reticulum; FAO; fatty acid beta-oxidation; JC-1; 5,5â²,6,6â
Keywords: ROI; reactive oxygen intermediates; VEGF; vascular endothelial growth factor; Arg-1; Arginase-1; HO-1; Heme Oxygenase-1; SRXN1; Sulphiredoxin-1; iNOS; inducible nitric oxide synthase; Th1; T-helper cells1; IFN-γ; interferon gamma; IL-4; interleukin-4; Th
Keywords: Ala; alanine; Arg; arginine; CR; caloric restriction; GH; growth hormone; GHR; growth hormone receptor; GHRH; growth hormone-releasing hormone; IGF-1; insulin-like growth factor 1; IL; interleukin; IKKα/β; inhibitor of nuclear factor kappa-B kinase α/Î
Keywords: CCL; chemokine (CC-motif) ligand; CD; cluster of differentiation; CXCL; chemokine (CXC-motif) ligand; IL; interleukin; KD; knock-down; KO; knock-out; LPS; lipopolysaccharide; NT; non-target; PC; proprotein convertase; STAT; signal transducer and activator
Keywords: AD; Alzheimer's disease; ARA; arachidonic acid; CD; cluster of differentiation; iPLA2; calcium independent phospholipase A2; cPLA2; cytosolic phospholipase A2; DHA; docosahexaenoic acid; EPA; eicosapentaenoic acid; HDHA; hydroxy DHA; HETE; hydroxyeicosa
Keywords: RT; radiation therapy; IFN-γ; interferon-γ; TLR; toll-like receptor; STAT; signal transducer and activator of transcription; NF-κB; nuclear factor-κB; CXCLs; C-X-C motif ligands; CCLs; C-C motif ligands; iNOS; inducible nitric oxide synthase; IL; inte
Keywords: Systemic sclerosis; Fibrosis; Myofibroblast; Innate; Immunity; Macrophages; TLR; Methylation;
Keywords: aCL; anticardiolipin; ADP; adenosine diphosphate; APOH; apolipoprotein H; APS; antiphospholipid syndrome; β2GPI; β2-glycoprotein I; DVT; deep vein thrombosis; FDR; false discovery rate; GO; gene ontology; IL; interleukin; IRAK 1; interleukin-1 receptor-
Keywords: biodegradable polymers; bioresorbable vascular scaffold; bleeding; drug-eluting stent; percutaneous coronary intervention; stent restenosis; stent thrombosis; 1G-DES; first-generation drug-eluting stent(s); 2G-DES; second-generation drug-eluting stent(s);
Keywords: Mucosal immunity; oral tolerance; dendritic cells; regulatory T cells; allergy; ALDH; Aldehyde dehydrogenase; APC; Antigen-presenting cell; BALF; Bronchoalveolar lavage fluid; cDC; Conventional dendritic cells; CFA; Complete Freund adjuvant; DC; Dendritic